201 related articles for article (PubMed ID: 8542510)
1. Synchronous multifocal bone sarcomas--a case report and molecular pathologic investigation.
Walter H; Schneider-Stock R; Mellin W; Günther T; Nebelung W; Roessner A
Gen Diagn Pathol; 1995 May; 141(1):67-74. PubMed ID: 8542510
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.
Bovée JV; Cleton-Jansen AM; Rosenberg C; Taminiau AH; Cornelisse CJ; Hogendoorn PC
J Pathol; 1999 Dec; 189(4):454-62. PubMed ID: 10629543
[TBL] [Abstract][Full Text] [Related]
3. Juxtacortical dedifferentiated chondrosarcoma from a primary periosteal chondrosarcoma.
Mitchell A; Rudan JR; Fenton PV
Mod Pathol; 1996 Mar; 9(3):279-83. PubMed ID: 8685228
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyosarcomatous component in dedifferentiated chondrosarcoma.
Niezabitowski A; Edel G; Roessner A; Grundmann E; Timm C; Wuisman P
Pathol Res Pract; 1987 Apr; 182(2):275-82. PubMed ID: 3601806
[TBL] [Abstract][Full Text] [Related]
5. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R
Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis.
Bridge JA; DeBoer J; Travis J; Johansson SL; Elmberger G; Noel SM; Neff JR
Am J Pathol; 1994 Feb; 144(2):215-20. PubMed ID: 8311109
[TBL] [Abstract][Full Text] [Related]
7. Primary malignant giant cell tumor of bone: "dedifferentiated" giant cell tumor.
Meis JM; Dorfman HD; Nathanson SD; Haggar AM; Wu KK
Mod Pathol; 1989 Sep; 2(5):541-6. PubMed ID: 2554283
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
Hisaoka M; Morimitsu Y; Hashimoto H; Ishida T; Mukai H; Satoh H; Motoi T; Machinami R
Am J Surg Pathol; 1999 Dec; 23(12):1480-92. PubMed ID: 10584701
[TBL] [Abstract][Full Text] [Related]
9. [Dedifferentiated chondrosarcoma with maxillary involvement. An anatomo-clinical study, surgical treatment and prosthetic rehabilitation. Apropos of a case].
Paume P; Grippari JL; Payement G; Dandrau JP; Cariou JL; Bellavoir A
Rev Stomatol Chir Maxillofac; 1993; 94(2):104-9. PubMed ID: 8389488
[TBL] [Abstract][Full Text] [Related]
10. Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma.
Grote HJ; Schneider-Stock R; Neumann W; Roessner A
Virchows Arch; 2000 May; 436(5):494-7. PubMed ID: 10881744
[TBL] [Abstract][Full Text] [Related]
11. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract][Full Text] [Related]
12. [Cytogenesis and histogenesis of malignant and semimalignant bone tumors].
Roessner A; Grundmann E
Veroff Pathol; 1984; 122():1-195. PubMed ID: 6091360
[TBL] [Abstract][Full Text] [Related]
13. [Current topics in the diagnosis and treatment of malignant fibrous histiocytoma].
Chuman H
Gan To Kagaku Ryoho; 2003 May; 30(5):626-33. PubMed ID: 12795093
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of a cell line from a malignant fibrous histiocytoma of bone developing in a patient with multiple fibrous dysplasia.
Fang Z; Mukai H; Nomura K; Shinomiya K; Matsumoto S; Kawaguchi N; Kitagawa T; Kanda H
J Cancer Res Clin Oncol; 2002 Jan; 128(1):45-9. PubMed ID: 11862471
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
16. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
[TBL] [Abstract][Full Text] [Related]
17. Laminin matrix formation and S-100 protein and/or desmin-positive cells in malignant fibrous histiocytoma (MFH).
Kosmehl H; Langbein L; Katenkamp D; Vogel W; Berndt A
Histol Histopathol; 1993 Jul; 8(3):425-8. PubMed ID: 8395262
[TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of bone GLA protein in primary bone tumors.
Iwasaki R; Yamamuro T; Kotoura Y; Okumura H; Kasai R; Nakashima Y
Cancer; 1992 Aug; 70(3):619-24. PubMed ID: 1320449
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a fibrous histiocytoma cell line (NMSG 10) derived from a malignant fibrous histiocytoma.
Yokota T; Ishizaki R; Ohishi H; Ohami H
Pathol Res Pract; 1995 Dec; 191(12):1231-8. PubMed ID: 8927571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
